Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 12 | 2024 | 1007 | 2.920 |
Why?
|
| Dark Adaptation | 4 | 2021 | 222 | 2.370 |
Why?
|
| Metabolomics | 7 | 2024 | 1659 | 1.710 |
Why?
|
| Wet Macular Degeneration | 4 | 2019 | 162 | 1.600 |
Why?
|
| Choroid | 5 | 2022 | 360 | 1.270 |
Why?
|
| Retinal Drusen | 3 | 2021 | 74 | 0.900 |
Why?
|
| Retinal Necrosis Syndrome, Acute | 1 | 2022 | 24 | 0.800 |
Why?
|
| Tomography, Optical Coherence | 13 | 2024 | 2917 | 0.790 |
Why?
|
| Vision, Monocular | 1 | 2022 | 71 | 0.790 |
Why?
|
| Choroidal Neovascularization | 3 | 2022 | 363 | 0.740 |
Why?
|
| Retinal Detachment | 2 | 2022 | 428 | 0.730 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2021 | 86 | 0.710 |
Why?
|
| Vision, Binocular | 1 | 2022 | 226 | 0.710 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2021 | 204 | 0.690 |
Why?
|
| Geographic Atrophy | 2 | 2019 | 91 | 0.680 |
Why?
|
| Visual Acuity | 10 | 2024 | 2672 | 0.660 |
Why?
|
| Diabetic Retinopathy | 5 | 2022 | 1274 | 0.650 |
Why?
|
| Body Fluids | 1 | 2019 | 320 | 0.560 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 877 | 0.490 |
Why?
|
| Metabolome | 3 | 2024 | 989 | 0.450 |
Why?
|
| Vitreous Body | 3 | 2022 | 399 | 0.440 |
Why?
|
| Retinal Diseases | 2 | 2019 | 705 | 0.430 |
Why?
|
| Retina | 3 | 2019 | 2659 | 0.430 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 341 | 0.420 |
Why?
|
| Retinal Vein Occlusion | 2 | 2024 | 149 | 0.410 |
Why?
|
| Fluorescein Angiography | 7 | 2024 | 1059 | 0.400 |
Why?
|
| Macular Edema | 3 | 2022 | 374 | 0.390 |
Why?
|
| Lipids | 2 | 2018 | 3341 | 0.340 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 26125 | 0.310 |
Why?
|
| Intravitreal Injections | 4 | 2024 | 385 | 0.300 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1052 | 0.300 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2024 | 2047 | 0.290 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5336 | 0.250 |
Why?
|
| Physicians | 1 | 2023 | 4591 | 0.250 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2018 | 251 | 0.250 |
Why?
|
| Prospective Studies | 12 | 2024 | 54425 | 0.210 |
Why?
|
| Aged | 23 | 2024 | 169289 | 0.200 |
Why?
|
| Macula Lutea | 1 | 2023 | 177 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2024 | 3492 | 0.190 |
Why?
|
| Polyps | 1 | 2022 | 200 | 0.180 |
Why?
|
| Portugal | 4 | 2024 | 91 | 0.180 |
Why?
|
| Aged, 80 and over | 11 | 2024 | 58976 | 0.170 |
Why?
|
| Middle Aged | 19 | 2024 | 220895 | 0.160 |
Why?
|
| Ciliary Arteries | 1 | 2019 | 19 | 0.160 |
Why?
|
| Empathy | 1 | 2023 | 473 | 0.160 |
Why?
|
| Carotid Artery, Internal | 1 | 2021 | 445 | 0.160 |
Why?
|
| Retinal Telangiectasis | 1 | 2019 | 25 | 0.160 |
Why?
|
| Humans | 35 | 2024 | 761504 | 0.160 |
Why?
|
| Female | 24 | 2024 | 392644 | 0.150 |
Why?
|
| Male | 24 | 2024 | 360804 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 3769 | 0.150 |
Why?
|
| Lenses, Intraocular | 1 | 2019 | 139 | 0.150 |
Why?
|
| Choroid Diseases | 1 | 2018 | 63 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2021 | 1638 | 0.140 |
Why?
|
| Melanoma | 1 | 2016 | 5709 | 0.140 |
Why?
|
| Phacoemulsification | 1 | 2018 | 149 | 0.140 |
Why?
|
| Specialty Boards | 1 | 2018 | 235 | 0.140 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2018 | 191 | 0.140 |
Why?
|
| Life Style | 2 | 2018 | 3917 | 0.140 |
Why?
|
| Visual Field Tests | 1 | 2019 | 411 | 0.130 |
Why?
|
| Retinal Vessels | 2 | 2024 | 852 | 0.130 |
Why?
|
| Endophthalmitis | 1 | 2019 | 260 | 0.130 |
Why?
|
| Eye Infections, Bacterial | 1 | 2019 | 242 | 0.130 |
Why?
|
| Sensory Thresholds | 1 | 2017 | 377 | 0.130 |
Why?
|
| Drug Substitution | 1 | 2018 | 290 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 303 | 0.120 |
Why?
|
| Photography | 1 | 2018 | 532 | 0.120 |
Why?
|
| Vision Disorders | 2 | 2019 | 1088 | 0.120 |
Why?
|
| Perioperative Care | 2 | 2019 | 1033 | 0.110 |
Why?
|
| Cataract | 1 | 2019 | 832 | 0.110 |
Why?
|
| Visual Fields | 1 | 2019 | 1062 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 39106 | 0.100 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 740 | 0.100 |
Why?
|
| SEER Program | 1 | 2016 | 1450 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2018 | 1948 | 0.090 |
Why?
|
| Medicine | 1 | 2018 | 942 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2192 | 0.090 |
Why?
|
| Health Personnel | 1 | 2023 | 3335 | 0.080 |
Why?
|
| Fundus Oculi | 2 | 2024 | 556 | 0.080 |
Why?
|
| Anxiety | 1 | 2023 | 4573 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2018 | 2690 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2199 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2018 | 2598 | 0.070 |
Why?
|
| Rural Population | 1 | 2018 | 2285 | 0.070 |
Why?
|
| Incidence | 4 | 2019 | 21353 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2018 | 22176 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12148 | 0.070 |
Why?
|
| Risk Factors | 5 | 2022 | 74206 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 4028 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12690 | 0.060 |
Why?
|
| Comorbidity | 1 | 2018 | 10508 | 0.050 |
Why?
|
| Logistic Models | 1 | 2018 | 13255 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2018 | 9318 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2018 | 4792 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2023 | 253 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2024 | 41487 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12463 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2022 | 80636 | 0.050 |
Why?
|
| Phenotype | 1 | 2018 | 16591 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2016 | 7967 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7407 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2018 | 12953 | 0.040 |
Why?
|
| Eye, Artificial | 1 | 2019 | 18 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15842 | 0.040 |
Why?
|
| Statistical Distributions | 1 | 2018 | 63 | 0.040 |
Why?
|
| Albuminuria | 1 | 2022 | 657 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5880 | 0.040 |
Why?
|
| Angiography | 1 | 2023 | 1595 | 0.040 |
Why?
|
| Drug Implants | 1 | 2018 | 230 | 0.040 |
Why?
|
| Indocyanine Green | 1 | 2019 | 233 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 23995 | 0.030 |
Why?
|
| Ocular Hypertension | 1 | 2018 | 209 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2019 | 562 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15631 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
| Triglycerides | 1 | 2022 | 2461 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 36192 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1813 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2880 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42230 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 1971 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2018 | 1596 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2018 | 2645 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36426 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2024 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2161 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29625 | 0.020 |
Why?
|
| United States | 1 | 2016 | 72334 | 0.020 |
Why?
|
| Child | 1 | 2016 | 80153 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 88319 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10766 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 168459 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 221177 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4063 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13506 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15732 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20098 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10773 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64680 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59243 | 0.010 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_